View study details on clinicaltrials.gov.
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Targeted Intra-arterial Gemcitabine vs. Continuation of IV Gemcitabine Plus Nab-Paclitaxel Following Induction With Sequential IV Gemcitabine Plus Nab-Paclitaxel and Radiotherapy for Locally Advanced Pancreatic Cancer (LAPC).
The study is a multi-center, un-blinded, randomized control study of subjects with locally advanced pancreatic adenocarcinoma which is unresectable.
Location: SIMR (Sacramento/Valley Area)
Please contact: SIMR@sutterhealth.org about TIGeR-PaC Study
Brian K. Kim, M.D, Deepti Behl, MD, Sivakumar Reddy, M.D., Vijay Suhag, M.D.